ReShape Lifesciences Inc.

0.64
-0.02 (-3.61%)
At close: Mar 24, 2025, 3:59 PM
0.63
-1.80%
After-hours: Mar 24, 2025, 04:11 PM EDT

ReShape Lifesciences Income Statement

Year FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12 FY11 FY10 FY09 FY08 FY07 FY06 FY05 FY04 FY03
Revenue 8.68M 11.24M 13.6M 11.3M 15.09M 606.71K 1.29M 786.66K 292K n/a n/a 312K n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost of Revenue 3.13M 4.44M 5.25M 5.04M 5.78M 164.3K 936.39K 431.48K 125K n/a n/a 232K n/a n/a n/a n/a n/a n/a n/a n/a n/a
Gross Profit 5.55M 6.8M 8.35M 6.26M 9.3M 442.41K 350.77K 355.18K 167K n/a n/a 80K n/a n/a n/a n/a n/a n/a n/a n/a n/a
Operating Income -14.64M -27.08M -27.75M -12.46M -15.89M -38.55M -31.41M -22.8M -27.87M -25.59M -24.73M -22.55M -25.26M -16.18M -24.21M -36.27M -28.03M -18.12M -11.15M -3.45M -1.9M
Interest Income n/a 113K 832K 2.05M 451K n/a 1.07K 5.84K 1.82K 3.33K 5.72K 9.88K 12.24K 5.6K 79.36K 1.1M 1.56M 1.14M 109.88K n/a n/a
Pretax Income -11.34M -46.59M -62.04M -21.81M -75.1M -38.71M -36.13M -23.36M -25.5M -26.13M -25.78M -23.46M -25.29M -17.35M -31.93M -36.29M -28.48M -18.12M -11.14M n/a n/a
Net Income -11.39M -46.21M -61.93M -21.63M -74.21M -81.15M -33.82M -23.36M -25.5M -26.13M -25.78M -23.46M -26M -17.35M -31.93M -37.87M -28.58M -17.69M -11.22M -3.45M -1.9M
Selling & General & Admin 17.87M 31.34M 33.58M 15.22M 22.07M 19.26M 25.98M 17.98M 19.89M 14.56M 13.66M 11.96M 8.58M 7.68M 8.63M 8.6M 6.97M 3.76M 2.32M n/a n/a
Research & Development 2.31M 2.54M 2.52M 3.5M 3.12M 5.72M 5.78M 5.17M 8.14M 11.03M 11.07M 10.67M 16.67M 8.5M 15.58M 27.67M 21.05M 14.36M 8.83M n/a n/a
Other Expenses n/a 11K 23.5M 306K -1.34M -10.64K -652 n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a -3.45M -1.9M
Operating Expenses 20.19M 33.88M 36.1M 18.72M 25.19M 24.98M 31.76M 23.15M 28.03M 25.59M 24.73M 22.63M 25.26M 16.18M 24.21M 36.27M 28.03M 18.12M 11.15M -3.45M -1.9M
Interest Expense n/a 113K 832K 2.05M 451K 12.38K 3.87K 4.1M 939.18K 530.22K 932.36K 901.84K 722.86K 1.26M 4.1M 2.68M 1.65M 710.11K 181.15K n/a n/a
Selling & Marketing Expenses 7.55M 14.09M 9.16M 4.69M 4.85M 5.24M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses 23.32M 38.32M 41.35M 23.76M 30.98M 25.15M 32.7M 23.58M 28.16M 25.59M 24.73M 22.86M 25.26M 16.18M 24.21M 36.27M 28.03M 18.12M 11.15M -3.45M -1.9M
Income Tax 52K -380K -106K -181K -893K -3.45M -2.31M 3.96M -2.56M 347.1K 872.37K -226.99K 740.74K 794.24K 7.29M 1.6M 549.15K -431.34K 62.91K 3.45M 1.9M
Shares Outstanding (Basic) 102.7K 7.32K 3.77K 1.35K 1.62K 218.81 192.14 48.53 191.98 n/a n/a 13.63K 10.42K 2.9K 1.72K 5.81K 843.10 178.43 134.17 48.81 54.83
Shares Outstanding (Diluted) 102.7K 7.32K 3.77K 1.35K 1.62K 218.81 192.14 48.53 191.98 n/a n/a 13.63K 10.42K 2.9K 1.72K 5.81K 843.10 178.43 134.17 48.81 54.83
EPS (Basic) -110.88 -6.32K -16.44K -48.19K -137.17K -370.88K -176.01K -481.39K -132.82K n/a n/a -1.72K -2.5K -5.98K -18.61K -6.52K -33.89K -99.14K -83.59K -70.66K -34.67K
EPS (Diluted) -110.88 -6.32K -16.44K -48.19K -137.17K -370.88K -176.01K -481.39K -132.82K n/a n/a -1.72K -2.5K -5.98K -18.61K -6.52K -33.89K -99.14K -83.59K -70.66K -34.67K
EBITDA -14.48M -24.93M -60.62M -18.09M -17.22M -36.97M -34.39M -19.5M -27.68M -25.4M -24.56M -22.32M -24.92M -15.01M -16.5M -35.74M -26.58M -18.03M -11.02M -3.45M -1.9M
Depreciation & Amortization 154K 2.15M 1.97M 1.67M 894K 581K 330K 192K 188.61K 188.9K 174.63K 226.99K 303.97K 375.76K 424.35K 513.06K 992.37K 95.85K 143.23K n/a n/a